key: cord-1033605-3wy1qiz6
authors: Cao, Jing; Devaraj, Sridevi
title: COVID-19 in Pediatrics: A Laboratory Perspective
date: 2020-04-15
journal: J Appl Lab Med
DOI: 10.1093/jalm/jfaa065
sha: adc4b1de1cb0e70be9ca503337eba15906839e00
doc_id: 1033605
cord_uid: 3wy1qiz6

nan

was 7 years (interquartile range: 2-13), and 1213 cases (56.6%) were male.

In the report from China by February 11th, 2020 (2) with 416 children younger than 10 years, 134 cases had the clinical records documented. Most of the infections in children were diagnosed from familial clusters. The main clinical manifestations in children were fever (76.1%), cough, followed by vomiting, diarrhea and other digestive system symptoms, and viral pneumonia-like changes in chest imaging (70.4%). Two critical cases that progressed rapidly to respiratory failure after onset have been reported in China, one with congenital heart disease and the other with bilateral hydronephrosis and calculus of left kidney (1, 4) . Compared to infected adults, children tend to have milder clinical symptoms, faster recovery, and better prognosis. On the other hand, the asymptomatic infected children may act as "carriers" and potentially shed virus and poses a serious challenge to people in close contact, especially pediatric medical workers. Notably, although positive viral nucleic acid test is the "gold standard", some cases need two or even three tests to be confirmed , so clinical "false negative" children with negative nucleic acid testing results may still be potential source of infection. It is suggested that in clinical suspected cases, continuous and repeated sample collections are need to improve the accuracy (4).

and suspected cases (N=1412) of children (3) . Suspected cases were identified based on two of the three following conditions after excluding influenza and other common respiratory infections: 1) fever or respiratory symptoms or digestive symptoms or fatigue; 2) normal or decreased white blood cell count with decreased lymphocyte count or increased C-reactive protein levels; 3) abnormal chest X-ray imaging (pneumonia-like changes) and ground glass opacities on chest computed tomography. Suspected cases meeting either one of the following criteria were defined as confirmed cases: 1). Nasal and pharyngeal swab specimens or blood samples tested positive for 2019-nCoV nucleic acid using realtime reverse-transcriptase polymerase-chain-reaction (RT-PCR) assay; 2) Genetic sequencing of respiratory tract or blood samples is highly homologous Regarding laboratory tests, based on the several articles on pediatric patients cited above (1, 2, 4) and an all-age study with 1099 patients that included 9 patients aged 0-14 yrs (6) , no differences have been reported in clinical findings between children and adults. Lippi and Plebani et al has summarized laboratory findings from published literature (7) and we hereby show in Table 1 the characteristic laboratory findings in children. In the early stage of the onset, the total number of white blood cells in the peripheral blood was normal or decreased, the lymphocyte count decreased, and some patients had decreased albumin and increased liver enzymes, muscle enzymes, including increased CK and myoglobin and increased lactate dehydrogenase (LDH). Most patients had normal or slightly elevated C-reactive protein, increased erythrocyte sedimentation rate and normal procalcitonin. In severe cases, D-dimer as well as procalcitonin increases, ferritin levels increase and the number of peripheral blood lymphocytes decreases progressively (Table) These children could be potential sources of infection. The asymptomatic pneumonia found in pediatric patients indicates follow up for these patients should include pulmonary function assessment. To date, critical cases in children identified all hadunderlying conditions and progressed rapidly, so children with underlying diseases should be aggressively protected by early isolation. Although no laboratory evidence for mother-to-child vertical transmission has been found, the fact that up to 10% neonates born to infected mothers developed symptomatic COVID-19still suggests that vertical transmission cannot be ruled out and newborns from infected mothers should be isolated immediately after delivery to avoid postnatal exposure.

Biochemical features in pediatric patients will be further defined with increased number of confirmed patients in the pediatric ages, who have not thus far been tested because of mild clinical symptoms. Biochemical findings in children, along with levels of cytokines and T-cell responses in this population, as well assessment of antibody titres, may give us mechanistic insights into SARS-CoV-2 infection, morbidity and mortality.

Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement

Institute of Pediatrics of Zhejiang University; 2020. 2. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team

Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

Corona Virus Disease 2019, a growing threat to children?

SARS-CoV-2 Infection in Children

Clinical Characteristics of Coronavirus Disease 2019 in China

Laboratory abnormalities in patients with COVID-2019 infection

Clinical analysis of pediatric SARS cases in Beijing

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr